A new home use SWD device enters market showing co
Post# of 7791
(Total Views: 193)
Posted On: 08/22/2023 11:13:20 AM
A new home use SWD device enters market showing continued demand for Non-Drug therapy
NEUROLOGICAL
Regenesis Rolls Out Reprieve Device for Home Pain Treatment
Sam Brusco, Associate Editor 08.22.23
"According to the company, Reprieve is the only home-use, shortwave diathermy device on the market. It’s based on Regenesis’ pulsed electromagnetic technology platform."
""In alignment with our Vision to improve health for a longer, more active, and fulfilling life, we are pleased to announce we received [FDA] clearance for our new Reprieve by Regenesis device," Tom Eisiminger, Regenesis president and CEO told the press."
"Regenesis researches, designs, manufactures, and sells energy-based products to alleviate pain, restore health, and improve quality of life. Focusing on veterans’ needs via direct salesforce, the company claims over 23,000 patients have been treated with its non-drug, electromagnetic energy to manage pain."
https://www.mpo-mag.com/contents/view_breakin...ment/24664
The Reprieve operates at the same 27.12 Mhz signal as the ActiPatch and has a Continuous Mode for heating tissue and a Pulsed Mode for less heat and more of a PEMF type treatment. It is a Prescription Only device.
NEUROLOGICAL
Regenesis Rolls Out Reprieve Device for Home Pain Treatment
Sam Brusco, Associate Editor 08.22.23
"According to the company, Reprieve is the only home-use, shortwave diathermy device on the market. It’s based on Regenesis’ pulsed electromagnetic technology platform."
""In alignment with our Vision to improve health for a longer, more active, and fulfilling life, we are pleased to announce we received [FDA] clearance for our new Reprieve by Regenesis device," Tom Eisiminger, Regenesis president and CEO told the press."
"Regenesis researches, designs, manufactures, and sells energy-based products to alleviate pain, restore health, and improve quality of life. Focusing on veterans’ needs via direct salesforce, the company claims over 23,000 patients have been treated with its non-drug, electromagnetic energy to manage pain."
https://www.mpo-mag.com/contents/view_breakin...ment/24664
The Reprieve operates at the same 27.12 Mhz signal as the ActiPatch and has a Continuous Mode for heating tissue and a Pulsed Mode for less heat and more of a PEMF type treatment. It is a Prescription Only device.
(1)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼